TD Asset Management’s Zymeworks ZYME Stock Holding History

TD Asset Management’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-42,262	Closed	-$693K	–	1515
2021 Q4	$693K	Hold	42,262	–	–	﹤0.01%	1342
2021 Q3	$1.23M	Buy	42,262 +9,900	+31%	+$329K	﹤0.01%	1206
2021 Q2	$1.04M	Hold	32,362	–	–	﹤0.01%	1250
2021 Q1	$1.02M	Buy	32,362 +5,452	+20%	+$222K	﹤0.01%	1256
2020 Q4	$1.27M	Sell	26,910 -3,900	-13%	-$181K	﹤0.01%	1126
2020 Q3	$1.44M	Hold	30,810	–	–	﹤0.01%	997
2020 Q2	$1.11M	Buy	30,810 +400	+1%	+$14.7K	﹤0.01%	1032
2020 Q1	$1.08M	Sell	30,410 -3,505	-10%	-$143K	﹤0.01%	977
2019 Q4	$1.54M	Buy	33,915 +3,300	+11%	+$120K	﹤0.01%	987
2019 Q3	$759K	Buy	30,615 +18,900	+161%	+$474K	﹤0.01%	1107
2019 Q2	$258K	Buy	+11,715	New	+$215K	﹤0.01%	1269

Other funds holding ZYME

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

TD Asset Management's ZYME Position: Q1 2022 in Review

TD Asset Management sold out of Zymeworks (ZYME) in Q1 2022, closing a stake of 42,262 shares — an estimated $693K sold.

TD Asset Management first reported a position in ZYME in Q2 2019 and held it in 11 quarters. The position peaked at $1.54M in Q4 2019. 120 funds tracked by Wall St. Rank hold ZYME as of Q1 2022.

TD Asset Management reported no remaining Zymeworks position as of Q1 2022 after selling out during the quarter.
TD Asset Management sold 42,262 Zymeworks shares in Q1 2022, an estimated $693K.
TD Asset Management first reported a position in Zymeworks in Q2 2019 and held it in 11 quarters.
TD Asset Management's Zymeworks position peaked at $1.54M in Q4 2019.
120 funds tracked by Wall St. Rank held Zymeworks as of Q1 2022.

Based on TD Asset Management's 13F filing for Q1 2022, filed 10 May 2022.